Bio Medica Laboratories Reports H1 FY27 Financial Results
Bio Medica Laboratories Ltd · Financial Result · 13 Nov 2026, 11:01 pm
Bio Medica Laboratories Reports H1 FY27 Financial Results Bio Medica Laboratories reported standalone revenue from operations of ₹1,668.64 lakhs for the half-year ended 30th Sep'26, down 9.31% YoY from ₹1,839.90 lakhs in H1 FY26. Standalone net profit declined 45.53% YoY to ₹283.81 lakhs compared to ₹521.01 lakhs in the prior-year period. On a consolidated basis, revenue from operations reached ₹2,160.78 lakhs with a net profit of ₹312.54 lakhs. The company raised ₹4,241.25 lakhs via share capital and securities premium, lifting consolidated cash and cash equivalents to ₹2,510.34 lakhs.
Original exchange filing (PDF)
More announcements from Bio Medica Laboratories Ltd
- Monitoring Agency Report for the half year ended 30th September, 2026, issued by CARE Ratings Limited ( Monitoring Agency ), in respect of the utilization of proceeds raised through Initial Public Offer by the Company · 14 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the half year ended September 30, 2026 in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) 2015. · 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 13 Nov 2026
- BMLL : 13-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 05, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 13, 2026, To consider and approve the financial results for the period ended September 30, 2026 · 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 05 Nov 2026
- Non-Applicability of Corporate Governance Report for the 2nd Quarter Ended on 30th September, 2026. · 26 Oct 2026
